Ramses Ribot, MD

Dr Gilberto Lopes is a medical oncologist and researcher who focuses on new anticancer drug development and global oncology. He has published more than 270 scientific papers and has led hundreds of clinical trials. Dr Lopes was the main investigator of Keynote 42, a clinical trial that demonstrated the efficacy of the immunotherapy drug pembrolizumab in people living with lung cancer. This groundbreaking study led to one of the FDA approvals of pembrolizumab. Additionally, Dr Lopes has contributed significantly to the development of several chemotherapies and targeted medications that address specific molecular changes in tumors.

Devinder Singh, MD, is Chief of Plastic Surgery at the University of Miami Health System and professor of surgery in the Division of Plastic Surgery at the University of Miami Miller School of Medicine. Dr Singh earned his baccalaureate at Brown University and his medical degree at Columbia University College of Physicians and Surgeons. He completed his combined residency in general and plastic surgery at Yale New Haven Hospital in Connecticut. In 2011, Maryland Governor Martin O'Malley appointed Dr Singh to be the only plastic surgeon on the Board of Physicians. The medical board is responsible for protecting public health through efficient licensure, effective discipline, and regulatory promulgation.